JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robbins, J. M.
Right arrow Articles by Kaplan, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robbins, J. M.
Right arrow Articles by Kaplan, Y.
Journal of the American Podiatric Medical Association
Volume 98 Number 6 489-493 2008
Copyright © 2008 American Podiatric Medical Association

Mortality Rates and Diabetic Foot Ulcers

Is it Time to Communicate Mortality Risk to Patients with Diabetic Foot Ulceration?

Jeffrey M. Robbins, DPM *, Gerald Strauss, PhD *, David Aron, MD *, Jodi Long, DPM *, Jennifer Kuba, DPM * and Yelena Kaplan, DPM *

* Louis Stokes Cleveland Veterans’ Affairs Medical Center, Cleveland, OH.

Corresponding author: Jeffrey M. Robbins, DPM, Louis Stokes Cleveland VAMC, 10701 East Blvd, Cleveland, OH 44106 (E-mail: Jeffrey.Robbins{at}med.va.gov)

Abstract

Five-year mortality rates after new-onset diabetic ulceration have been reported between 43% and 55% and up to 74% for patients with lower-extremity amputation. These rates are higher than those for several types of cancer including prostate, breast, colon, and Hodgkin’s disease. These alarmingly high 5-year mortality rates should be addressed more aggressively by patients and providers alike. Cardiovascular diseases represent the major causal factor, and early preventive interventions to improve life expectancy in this most vulnerable patient cohort are essential. New-onset diabetic foot ulcers should be considered a marker for significantly increased mortality and should be aggressively managed locally, systemically, and psychologically. (J Am Podiatr Med Assoc 98(6): 489–493, 2008)




This article has been cited by other articles:


Home page
Diabetes CareHome page
M.-W. Sohn, T. A. Lee, R. M. Stuck, R. G. Frykberg, and E. Budiman-Mak
Mortality Risk of Charcot Arthropathy Compared With That of Diabetic Foot Ulcer and Diabetes Alone
Diabetes Care, May 1, 2009; 32(5): 816 - 821.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Podiatric Medical Association.